USAID-Supported HIV Prevention Trial Produces Disappointing Results, But Leads To Learning, Redoubled Efforts

USAID’s “IMPACTblog”: How Progress Works: A Disappointing Microbicides Trial and Why We’re Not Discouraged
David Stanton, director of USAID’s Office of HIV/AIDS, discusses “results released from a large USAID-supported trial [which] indicate that an antiretroviral-based vaginal gel may not be effective in reducing the risk of HIV infection in women when used before and after sex.” He says, “Although the answer wasn’t what we’d hoped, in the process of asking we have learned and grown, and we’ll redouble our efforts to take the next steps forward…” (2/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.